Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.

• Phase: Phase 4

Details

• Lead Sponsor: Innovative Medical
• Treatments: Bimatoprost; Travoprost

Criteria

Inclusion Criteria:

• · Male or female > 18 years of age

• Naive to treatment or washed off any ocular hypotensive agents

• Untreated IOP >19 mm Hg

• Diagnosis of open-angle glaucoma or ocular hypertension

• Ability to provide informed consent and likely to complete study

Exclusion Criteria:

• · Known contraindication to bimatoprost or travoprost, or any component of any study medication

• Uncontrolled systemic disease

• Active ocular disease other than glaucoma or ocular hypertension

• Required use of ocular medications other than the study medications during the study

• History of intraocular surgery within the last 3 months

• Prior discontinuation of any of the study medications for reasons related to efficacy or safety